{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T20:08:40Z","timestamp":1771618120550,"version":"3.50.1"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003653","name":"Korea National Institute of Health","doi-asserted-by":"crossref","award":["2022-NI-008"],"award-info":[{"award-number":["2022-NI-008"]}],"id":[{"id":"10.13039\/501100003653","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Human immunodeficiency virus-1 (HIV-1) is a hazardous pathogen responsible for causing acquired immunodeficiency syndrome (AIDS). HIV-1 provirus survives in latently infected cells for a long time, despite treatment with combinational anti-retroviral therapy (cART); therefore, it is considered as a major obstacle in HIV-1 treatment. Several strategies have been developed to selectively eliminate latently HIV-1-infected cells; however, clinical success has not yet been reported. Here, we identified several key factors associated with cell apoptosis, which were upregulated in latently infected cells. Subsequently, we screened compounds targeting these factors to selectively kill latently HIV-1-infected cells. Among these, ABT-263 (Navitoclax), a BCL-2 inhibitor, exhibited a potent and selective killing effect on latently HIV-1-infected cells and exerted synergistic effects with combinations of other compounds targeting myeloid cell leukemia-1 (MCL-1), X-linked inhibitor of apoptosis protein (XIAP), and BAX. In an <jats:italic>ex vivo<\/jats:italic> model, latently HIV-1-infected memory CD4<jats:sup>+<\/jats:sup> T cells were efficiently eliminated via treatment with ABT-263 alone and its combinations with other modulatory compounds. Taken together, our results demonstrate that the balance of pro- and anti-apoptotic factors is crucial for the survival of latently HIV-1-infected cells. Thus, disrupting this balance using ABT-263 or combinations having ABT-263 without proviral reactivation may be useful for developing a novel strategy to eliminate latently infected cells in individuals infected with HIV-1.<\/jats:p>","DOI":"10.1371\/journal.pone.0322962","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T17:31:47Z","timestamp":1747762307000},"page":"e0322962","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["ABT-263, a BCL-2 inhibitor, selectively eliminates latently HIV-1-infected cells without viral reactivation"],"prefix":"10.1371","volume":"20","author":[{"given":"Jeong Eun","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0298-8254","authenticated-orcid":true,"given":"Hyun Wook","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Eun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Hyun","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songmee","family":"Bae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5696-0567","authenticated-orcid":true,"given":"Cheol-Hee","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"issue":"2","key":"pone.0322962.ref001","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1473-3099(18)30647-9","article-title":"Global and regional molecular epidemiology of HIV-1, 1990-2015: a systematic review, global survey, and trend analysis","volume":"19","author":"J Hemelaar","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"10425","key":"pone.0322962.ref002","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0140-6736(23)01381-8","article-title":"HIV epidemiology, prevention, treatment, and implementation strategies for public health","volume":"403","author":"A Mody","year":"2024","journal-title":"Lancet"},{"issue":"4","key":"pone.0322962.ref003","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nrmicro2747","article-title":"The structural biology of HIV-1: mechanistic and therapeutic insights","volume":"10","author":"A Engelman","year":"2012","journal-title":"Nat Rev Microbiol"},{"issue":"6","key":"pone.0322962.ref004","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1365-2796.2011.02457.x","article-title":"HIV reservoirs and the possibility of a cure for HIV infection","volume":"270","author":"S Palmer","year":"2011","journal-title":"J Intern Med"},{"issue":"15","key":"pone.0322962.ref005","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.2174\/0929867054367211","article-title":"Antiretroviral compounds: mechanisms underlying failure of HAART to eradicate HIV-1","volume":"12","author":"M Shehu-Xhilaga","year":"2005","journal-title":"Curr Med Chem"},{"issue":"6","key":"pone.0322962.ref006","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3018(18)30039-0","article-title":"Barriers and strategies to achieve a cure for HIV","volume":"5","author":"MC Pitman","year":"2018","journal-title":"Lancet HIV"},{"issue":"4","key":"pone.0322962.ref007","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/01926230701320337","article-title":"Apoptosis: a review of programmed cell death","volume":"35","author":"S Elmore","year":"2007","journal-title":"Toxicol Pathol"},{"issue":"6","key":"pone.0322962.ref008","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/cbin.11137","article-title":"Cell death: a review of the major forms of apoptosis, necrosis and autophagy","volume":"43","author":"MS D\u2019Arcy","year":"2019","journal-title":"Cell Biol Int"},{"issue":"1","key":"pone.0322962.ref009","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1080\/21505594.2019.1605803","article-title":"The roles of apoptosis, autophagy and unfolded protein response in arbovirus, influenza virus, and HIV infections","volume":"10","author":"P Mehrbod","year":"2019","journal-title":"Virulence"},{"key":"pone.0322962.ref010","doi-asserted-by":"crossref","first-page":"780400","DOI":"10.3389\/fimmu.2021.780400","article-title":"SMAC mimetics as therapeutic agents in HIV infection","volume":"12","author":"B Molyer","year":"2021","journal-title":"Front Immunol"},{"issue":"97","key":"pone.0322962.ref011","first-page":"220","article-title":"Apoptosis in HIV-1 infection","author":"MF Cotton","year":"1996","journal-title":"Behring Inst Mitt"},{"issue":"6830","key":"pone.0322962.ref012","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/35071111","article-title":"HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell","volume":"410","author":"R Geleziunas","year":"2001","journal-title":"Nature"},{"issue":"1","key":"pone.0322962.ref013","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12985-016-0595-2","article-title":"Highly activated p53 contributes to selectively increased apoptosis of latently HIV-1 infected cells upon treatment of anticancer drugs","volume":"13","author":"Y Shin","year":"2016","journal-title":"Virol J"},{"issue":"7","key":"pone.0322962.ref014","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41419-020-02761-x","article-title":"SMAC mimetics induce autophagy-dependent apoptosis of HIV-1-infected macrophages","volume":"11","author":"GR Campbell","year":"2020","journal-title":"Cell Death Dis"},{"issue":"18","key":"pone.0322962.ref015","doi-asserted-by":"crossref","first-page":"9009","DOI":"10.7150\/thno.59728","article-title":"CD4+ T cell-mimicking nanoparticles encapsulating DIABLO\/SMAC mimetics broadly neutralize HIV-1 and selectively kill HIV-1-infected cells","volume":"11","author":"GR Campbell","year":"2021","journal-title":"Theranostics"},{"issue":"8","key":"pone.0322962.ref016","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.celrep.2018.07.079","article-title":"HIV-1-Infected CD4+ T cells facilitate latent infection of resting CD4+ T cells through cell-cell contact","volume":"24","author":"LM Agosto","year":"2018","journal-title":"Cell Rep"},{"issue":"1","key":"pone.0322962.ref017","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1038\/s41467-020-17753-w","article-title":"Clearance of HIV infection by selective elimination of host cells capable of producing HIV","volume":"11","author":"M Li","year":"2020","journal-title":"Nat Commun"},{"issue":"5","key":"pone.0322962.ref018","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/JLB.4MR0422-636R","article-title":"Current strategies to induce selective killing of HIV-1-infected cells","volume":"112","author":"GR Campbell","year":"2022","journal-title":"J Leukoc Biol"},{"key":"pone.0322962.ref019","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.3389\/fmicb.2018.02022","article-title":"Combination of a latency-reversing agent with a smac mimetic minimizes secondary HIV-1 infection in vitro","volume":"9","author":"S-I Hattori","year":"2018","journal-title":"Front Microbiol"},{"issue":"4","key":"pone.0322962.ref020","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1128\/jvi.66.4.2232-2239.1992","article-title":"Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene","volume":"66","author":"J Kimpton","year":"1992","journal-title":"J Virol"},{"issue":"2","key":"pone.0322962.ref021","doi-asserted-by":"crossref","first-page":"251","DOI":"10.5455\/OVJ.2021.v11.i2.9","article-title":"The MTT assay application to measure the viability of spermatozoa: A variety of the assay protocols","volume":"11","author":"K Buranaamnuay","year":"2021","journal-title":"Open Vet J"},{"issue":"1","key":"pone.0322962.ref022","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.3128","article-title":"Analysis of the mitochondrial membrane potential using the Cationic JC-1 dye as a sensitive fluorescent probe","volume":"9","author":"F Sivandzade","year":"2019","journal-title":"Bio Protoc"},{"key":"pone.0322962.ref023","article-title":"Flow cytometric analysis of mitochondrial membrane potential using JC-1","author":"A Cossarizza","year":"2001","journal-title":"Curr Protoc Cytom"},{"issue":"4","key":"pone.0322962.ref024","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.bbrc.2015.06.091","article-title":"Impaired IL-2 expression in latent HIV-1 infection","volume":"463","author":"Y Shin","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"pone.0322962.ref025","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1089\/aid.2015.0106","article-title":"Modeling HIV-1 latency in primary T cells using a replication-competent virus","volume":"32","author":"LJ Martins","year":"2016","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"1","key":"pone.0322962.ref026","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1182\/blood-2008-07-168393","article-title":"Induction of HIV-1 latency and reactivation in primary memory CD4+ T cells","volume":"113","author":"A Bosque","year":"2009","journal-title":"Blood"},{"issue":"12","key":"pone.0322962.ref027","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1097\/QAD.0000000000000309","article-title":"Genome-wide analysis of histone modifications in latently HIV-1 infected T cells","volume":"28","author":"J Park","year":"2014","journal-title":"AIDS"},{"key":"pone.0322962.ref028","doi-asserted-by":"crossref","first-page":"108760","DOI":"10.1016\/j.intimp.2022.108760","article-title":"Evaluation of plasma LC3B+extracellular vesicles as a potential novel diagnostic marker for hepatocellular carcinoma","volume":"108","author":"Y-Q Chen","year":"2022","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"pone.0322962.ref029","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.cell.2010.11.001","article-title":"Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue","volume":"143","author":"G Doitsh","year":"2010","journal-title":"Cell"},{"key":"pone.0322962.ref030","doi-asserted-by":"crossref","first-page":"524308","DOI":"10.1155\/2012\/524308","article-title":"The role of BCL2 family of apoptosis regulator proteins in acute and chronic leukemias","volume":"2012","author":"F Tzifi","year":"2012","journal-title":"Adv Hematol"},{"issue":"1","key":"pone.0322962.ref031","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00107-19","article-title":"The role of the BCL-2 family of proteins in HIV-1 pathogenesis and persistence","volume":"33","author":"AP Chandrasekar","year":"2019","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"pone.0322962.ref032","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41419-019-1407-6","article-title":"BCL-2 family isoforms in apoptosis and cancer","volume":"10","author":"CFA Warren","year":"2019","journal-title":"Cell Death Dis"},{"issue":"4","key":"pone.0322962.ref033","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.bbamcr.2015.12.016","article-title":"AT-101 simultaneously triggers apoptosis and a cytoprotective type of autophagy irrespective of expression levels and the subcellular localization of Bcl-xL and Bcl-2 in MCF7 cells","volume":"1863","author":"P Antonietti","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"pone.0322962.ref034","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1186\/s12885-015-1582-5","article-title":"Obatoclax is a direct and potent antagonist of membrane-restricted Mcl-1 and is synthetic lethal with treatment that induces Bim","volume":"15","author":"M Nguyen","year":"2015","journal-title":"BMC Cancer"},{"issue":"12","key":"pone.0322962.ref035","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00138-21","article-title":"The combination of venetoclax and ixazomib selectively and efficiently kills HIV-infected cell lines but has unacceptable toxicity in primary cell models","volume":"95","author":"A Alto","year":"2021","journal-title":"J Virol"},{"issue":"11","key":"pone.0322962.ref036","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00012-17","article-title":"Maintenance of the HIV reservoir is antagonized by selective BCL2 inhibition","volume":"91","author":"NW Cummins","year":"2017","journal-title":"J Virol"},{"issue":"5","key":"pone.0322962.ref037","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2018.09.007","article-title":"SMAC mimetics induce autophagy-dependent apoptosis of HIV-1-infected resting memory CD4+ T cells","volume":"24","author":"GR Campbell","year":"2018","journal-title":"Cell Host Microbe"},{"issue":"9","key":"pone.0322962.ref038","doi-asserted-by":"crossref","first-page":"101178","DOI":"10.1016\/j.xcrm.2023.101178","article-title":"Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice","volume":"4","author":"P Arandjelovic","year":"2023","journal-title":"Cell Rep Med"},{"issue":"23","key":"pone.0322962.ref039","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1097\/CM9.0000000000001797","article-title":"Selective elimination of host cells harboring replication-competent human immunodeficiency virus reservoirs: a promising therapeutic strategy for HIV cure","volume":"134","author":"SD Zaongo","year":"2021","journal-title":"Chin Med J (Engl)"},{"issue":"5","key":"pone.0322962.ref040","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/1097-0142(20010901)92:5<1122::AID-CNCR1429>3.0.CO;2-H","article-title":"BCL2 expression correlates with metastatic potential in pancreatic cancer cell lines","volume":"92","author":"RJ Bold","year":"2001","journal-title":"Cancer"},{"issue":"5","key":"pone.0322962.ref041","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.3109\/10428190109097729","article-title":"Causes and consequences of BCL2 overexpression in diffuse large B-cell lymphoma","volume":"42","author":"S Rantanen","year":"2001","journal-title":"Leuk Lymphoma"},{"issue":"7","key":"pone.0322962.ref042","article-title":"Prognostic influence of BCL2 expression in breast cancer","volume":"131","author":"K-T Hwang","year":"2012","journal-title":"Int J Cancer"},{"issue":"9","key":"pone.0322962.ref043","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1158\/0008-5472.CAN-07-5836","article-title":"ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor","volume":"68","author":"C Tse","year":"2008","journal-title":"Cancer Res"},{"key":"pone.0322962.ref044","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.phrs.2019.01.040","article-title":"Allosteric modulation of sigma receptors by BH3 mimetics ABT-737, ABT-263 (Navitoclax) and ABT-199 (Venetoclax)","volume":"142","author":"JR Lever","year":"2019","journal-title":"Pharmacol Res"},{"issue":"2","key":"pone.0322962.ref045","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3390\/cancers15020477","article-title":"AT-101 enhances the antitumor activity of lenalidomide in patients with multiple myeloma","volume":"15","author":"S Ailawadhi","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"49","key":"pone.0322962.ref046","doi-asserted-by":"crossref","first-page":"19512","DOI":"10.1073\/pnas.0709443104","article-title":"Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis","volume":"104","author":"M Nguyen","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"pone.0322962.ref047","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3390\/vaccines9050514","article-title":"Epigenetic mechanisms of HIV-1 persistence","volume":"9","author":"R Verdikt","year":"2021","journal-title":"Vaccines (Basel)"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0322962","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T17:32:00Z","timestamp":1747762320000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0322962"}},"subtitle":[],"editor":[{"given":"Kai","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":47,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0322962","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,20]]}}}